WEBULL
WebtradeDownload

iRhythm Holdings (IRTC) Stock Looks Reasonable Given Its Current Sales Base

Simply Wall St · 1d ago

iRhythm Holdings has seen its share price move around in recent years, and the current quote near US$111.75 raises a clear question for anyone following the story. Is the stock price you see today properly grounded in the sales the business is generating, or has the market run ahead of itself or lagged behind?

  • Over the past 5 years the stock has delivered a gain of about 92.2%, which puts real weight on whether that share price performance still lines up with the underlying sales base.
  • The business model leans on selling cardiac monitoring services and devices, so the pace at which it converts those clinical deployments into recurring revenue can shape how much sales investors are effectively paying for at today's price.
  • Your read on iRhythm Holdings is one view; the desks covering it have another. See what analysts think iRhythm Holdings's shares could be worth.

For investors, the debate is whether iRhythm Holdings' recent share price around US$111.75 is appropriately supported by the level and trajectory of its sales.

If you are weighing whether iRhythm Holdings' current valuation fairly reflects its sales, it can help to compare it with other companies screened for 30 high quality undervalued stocks

Does iRhythm Holdings Look Fairly Valued on Sales?

P/S fits iRhythm Holdings because investors are mainly paying for its revenue base rather than current earnings. On this measure, the stock trades on a P/S of about 4.5x, compared with an industry average near 2.9x for Medical Equipment and a peer group closer to 4.9x. That places the market value of each dollar of iRhythm Holdings sales above the broad sector but slightly below the narrower peer set.

The Fair Ratio model, which adjusts the P/S you might expect for iRhythm Holdings based on its growth profile, margins, size and risk, points to a level close to where the shares trade today. The current multiple sits a little above that tailored yardstick rather than meaningfully below it or far beyond it, so the price to sales signal here is neither screamingly cheap nor extremely expensive on this framework. Explore the numbers behind iRhythm Holdings's P/S valuation.

NasdaqGS:IRTC P/S Ratio as at Sep 2026
NasdaqGS:IRTC P/S Ratio as at Sep 2026

The iRhythm Holdings Narrative: What Would Justify Today's Price?

Narratives for iRhythm Holdings pick up where the valuation riddle leaves off. They spell out what kind of future path on growth, margins and earnings would need to play out for today’s share price to look materially higher or lower in hindsight. Each one anchors its number to a clear view on how the company’s expansion, profitability and risk profile might evolve, which you can revisit as fresh information comes through. These narratives are available on Simply Wall St’s Community page.

One of the top community narratives on iRhythm Holdings: 29% undervalued

"New diagnostic and AI tools, including those that let providers perform more of their own rhythm analysis, may change how value is split..."

Discover why this Narrative puts iRhythm Holdings at 29% undervalued.

Before acting on iRhythm Holdings' valuation, the people steering it deserve a closer look

The stock price only tells part of the story, because the track record, decisions and pay structure of the leadership team can heavily influence how this business converts its opportunities into results. See who runs iRhythm Holdings and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.